Correlation Between CohBar and ZyVersa Therapeutics
Can any of the company-specific risk be diversified away by investing in both CohBar and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CohBar and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CohBar Inc and ZyVersa Therapeutics, you can compare the effects of market volatilities on CohBar and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CohBar with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of CohBar and ZyVersa Therapeutics.
Diversification Opportunities for CohBar and ZyVersa Therapeutics
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between CohBar and ZyVersa is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding CohBar Inc and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and CohBar is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CohBar Inc are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of CohBar i.e., CohBar and ZyVersa Therapeutics go up and down completely randomly.
Pair Corralation between CohBar and ZyVersa Therapeutics
If you would invest 70.00 in CohBar Inc on February 22, 2024 and sell it today you would earn a total of 0.00 from holding CohBar Inc or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 4.55% |
Values | Daily Returns |
CohBar Inc vs. ZyVersa Therapeutics
Performance |
Timeline |
CohBar Inc |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
ZyVersa Therapeutics |
CohBar and ZyVersa Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with CohBar and ZyVersa Therapeutics
The main advantage of trading using opposite CohBar and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CohBar position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.CohBar vs. Enveric Biosciences | CohBar vs. Elevation Oncology | CohBar vs. Hepion Pharmaceuticals | CohBar vs. Zura Bio Limited |
ZyVersa Therapeutics vs. Morningstar Unconstrained Allocation | ZyVersa Therapeutics vs. Victory Sophus Emerging | ZyVersa Therapeutics vs. Spring Valley Acquisition | ZyVersa Therapeutics vs. CarMax Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |